Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Conditioned Serum for Knee Osteoarthritis
NCT03850080Phase 3Completed
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Oct 2017
- Primary completion
- Sep 2018
- Modality
- Biologic
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of autologous conditioned serum in knee osteoarthritis (OA), sponsored by IRCCS Ospedale San Raffaele. Primary endpoints: Western Ontario & McMaster Universities Osteoarthritis Index at 6 months, Knee Society Score at 6 months and 1 more. Started Oct 2017; status: completed.
02
Drugs
autologous conditioned serum
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03850080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03850080.